CMS-10152 NOPR referring_md_sheet

Data collection for Medicare Beneficiaries Receiving FDG Positron Emission Tomography (PET) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and All Other Cancers

NOPR referring_md_sheet

Collection for Medicare Bene#s Receiving FDG Positron Emissions Tomography for Brain, Cervical, Ovarian, Small Cell Lung, and Testicular Cancers

OMB: 0938-0968

Document [pdf]
Download: pdf | pdf
PET Facility Pre-Registration Form
Referring Physician Information Sheet
The purpose of the National Oncologic PET Registry (NOPR) is to prospectively examine how the use of PET scans
impacts the management of patients with suspected or known cancer. This information will be used to develop guidelines
for the effective use of PET in a variety of clinical situations and for future requests to the Centers for Medicare and
Medicaid Services (CMS) to seek coverage for PET for cancer types and indications that are not covered outside of this
registry.
Currently, CMS is providing coverage for PET performed for non-covered cancer types and indications under a new
program known as “coverage with evidence development” (CED). As a condition of payment, CMS requires that you
provide specific patient information before the PET scan and within 30 days after the PET scan. The information is
entered into a secure database maintained by the NOPR and forwarded to CMS for payment determination.
Your participation in the research component is voluntary. You may choose not to participate. If you agree to participate,
the NOPR investigators will also use the information you provide for research purposes. Your patient will also be asked
to allow his or her information to be used for the same research purposes. Your patient’s data and PET information in the
registry will be used for research only if both you and your patient provide consent. However, you or your patient may
choose not to allow this information to be used for the research component of the NOPR. If you choose not to participate,
your ability to request future PET scans will not be affected.
Whether or not you choose to participate, you will need to complete pre- and post-PET forms which are necessary for
payment by CMS. If you choose to participate in the research study, the same information will be become part of the
research data. The Pre-PET Completion Form, which must be completed before or on the day of the PET scan, will ask
you questions related to the reason for requesting the scan, the patient’s known or suspected cancer type and extent, and
the intended management plan if PET were not available. The Post-PET Form, which must be completed and returned to
the PET facility within 30 days after the PET scan, will ask you questions about the impact of the PET findings on your
assessment of the patient’s disease status and your current management plan for the patient.
You and your patient will not directly benefit from participating in the research component at this time. Your
participation will help to identify the most effective applications of PET in oncology patients. The information will be
used by CMS and other health insurance providers to decide whether to pay for PET scans for a wider range of cancer
types or cancer-related indications in the future. We hope that the decision may help patients with cancer in the future.
There are no direct risks or discomfort associated with your participation. However, the completion of the pre- and postPET forms is a requirement for CMS reimbursement. Completion of the forms should take approximately 3 minutes for
each form. Participation in the research component will not require additional time for you and your staff. Your patient
will not know your answers and of your participation in the research.
The NOPR has implemented the necessary infrastructure to ensure security of all data submitted on the pre- and post-PET
forms. However, we cannot guarantee total privacy. The information will be stored at the American College of
Radiology Imaging Network (ACRIN). NOPR investigators will only have access to this information for research
purposes, if you consent. All data collected through the NOPR will be made available to CMS for payment purposes
regardless of whether consent is given for the research component. The staff at the PET facility where the scan will be
performed will not be able to answer any questions concerning this research study. If you have any questions or require
any assistance, you can contact the NOPR project manager toll free at 800-227-5463, ext.4859, or
[email protected].

If you choose to participate and allow the information collected on the pre- and post-PET forms be used for the
research component of the NOPR, please check the appropriate check box to indicate your participation in the
NOPR research study on the Post-PET Form.


File Typeapplication/pdf
File TitleMicrosoft Word - nopr_referring_md_sheet.doc
Authorshartson
File Modified2006-04-26
File Created2006-04-26

© 2024 OMB.report | Privacy Policy